INCIVO data to be presented
Janssen Infectious Diseases-Diagnostics BVBA (Janssen) will present new data for INCIVO® (telaprevir) in combination with peginterferon alfa and ribavirin (PR) at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Washington DC, highlighting that earlier treatment improves patient outcomes.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: ebercott Tags: Industry News Infectious Disease Latest News Source Type: news
More News: Drugs & Pharmacology | Incivek | Infectious Diseases | Liver | Liver Disease | Study | Urology & Nephrology